Recently several physicians in Tennessee have taken a stand against the birth-control patch Ortho Evra. The risks associated with this drug were serious enough to compel these doctors to no longer prescribe Ortho Evra. Hundreds of patients from one Tennessee women’s health group received letters citing an American College of Gynecology study that showed a greater risk of deep vein thrombosis in women using Ortho Evra. Deep vein thrombosis is a blood clot that, in some cases, can break loose and travel through the blood stream to the lungs, causing a pulmonary embolism.

Ortho Evra is a once-a-week transdermal birth control patch that releases hormones that are absorbed directly into the bloodstream, as opposed to ingesting them into the body as with the traditional birth control pill. This causes an increased exposure to estrogen of up to 60%, putting users at a greater risk of developing dangerous adverse effects, including blood clots, pulmonary embolism, heart attack, stroke, deep vein thrombosis, and death. Thus far, we have filed several Ortho Evra lawsuits involving injuries like or similar to those described above. We are currently investigating and evaluating a number of other potential claims. Chad Cook is the lead lawyer handling these cases for our firm.

Other Related Articles

• An Update on Ortho Evra Litigation
• More Ortho Evra Lawsuits Being Filed Over Birth Control Patch
• Ortho Evra Lawsuit Update
• Ortho Evra Lawsuit Settles for $1.25 Million
• Ortho-Evra Patch Exposers Women To Dangerous Estrogen Levels And Risk Of Blood Clots